Wikidata

(Q38375842)

English

Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial

scientific article published on March 2010

In more languages

Statements

title
Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
author name string
Andrew R Zolopa
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
Daniel S Berger
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
Harry Lampiris
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
Lijie Zhong
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
Steven L Chuck
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
Jeffrey V Enejosa
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
Brian P Kearney
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
Andrew K Cheng
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
publication date
1 March 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017
page(s)
814-822
1 reference
stated in
Europe PubMed Central
PubMed ID
20146631
retrieved
2 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38375842&oldid=1756612974"